Search Results - "Balbuena, María E"
-
1
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study
Published in Journal of the neurological sciences (15-07-2024)“…We aimed to assess the treatment strategies utilized in patients with neuromyelitis optica spectrum disorder (NMOSD) experiencing relapses, including their…”
Get full text
Journal Article -
2
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting
Published in Multiple sclerosis (01-09-2023)“…Background: We aimed to assess the frequency of new asymptomatic lesions on brain and spinal imaging (magnetic resonance imaging (MRI)) and their association…”
Get full text
Journal Article -
3
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina
Published in Neurological sciences (01-02-2024)“…We aimed to evaluate the incidence of SARS-CoV-2 breakthrough infection of SARS-CoV-2 vaccines in people with MS (PwMS) on high-efficacy disease-modifying…”
Get full text
Journal Article -
4
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina
Published in Neurological sciences (2023)“…The objective was to evaluate time to reach an EDSS of 4, 6, and 7 in NMOSD and MOGAD patients included in the Argentinean MS and NMOSD registry (RelevarEM,…”
Get full text
Journal Article -
5
Seasonal variation in attacks of neuromyelitis optica spectrum disorders and multiple sclerosis: Evaluation of 794 attacks from a nationwide registry in Argentina
Published in Multiple sclerosis and related disorders (01-02-2022)“…•Seasonal variation has been reported in autoimmune diseases of the CNS, like MS.•We aimed to analyze the seasonality of NMOSD and MS attacks in…”
Get full text
Journal Article -
6
Consensus recommendations for family planning and pregnancy in multiple sclerosis in argentina
Published in Multiple sclerosis and related disorders (01-08-2020)“…•Multiple sclerosis itself does not make pregnancy high risk.•Disease stability is recommended for at least one year prior attempting pregnancy.•Disease…”
Get full text
Journal Article -
7
Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses
Published in Cell (10-09-2015)“…Seasonal changes in disease activity have been observed in multiple sclerosis, an autoimmune disorder that affects the CNS. These epidemiological observations…”
Get full text
Journal Article -
8
Sex-specific environmental influences affecting MS development
Published in Clinical immunology (Orlando, Fla.) (01-11-2013)“…Abstract Vitamin D status, smoking, and Epstein–Barr virus infection (EBV) may all contribute to explain differences in disease prevalence and incidence of…”
Get full text
Journal Article -
9
Autoimmune Disease Prevalence in a Multiple Sclerosis Cohort in Argentina
Published in Multiple Sclerosis International (01-01-2014)“…Background. Comorbid autoimmune diseases in MS patients have been studied extensively with controversial results. Moreover, no such data exists for…”
Get full text
Journal Article -
10
Obesity and the risk of Multiple Sclerosis. The role of Leptin
Published in Annals of clinical and translational neurology (01-02-2021)“…Objective To investigate the effects of leptin on different T‐cell populations, in order to gain more insight into the link between leptin and obesity. Methods…”
Get full text
Journal Article -
11
Low familial risks for multiple sclerosis in Buenos Aires, Argentina
Published in Journal of the neurological sciences (15-11-2014)“…Abstract Background Multiple sclerosis is a complex disease in which genetic susceptibility plays a role and familial occurrence has long been recognized. To…”
Get full text
Journal Article -
12
The Argentinean multiple sclerosis registry (RelevarEM): Methodological aspects and directions
Published in Multiple sclerosis and related disorders (01-07-2019)“…•No ongoing nationwide registry exists in Latin America.•We describe the methodology behind RelevarEM, the first nationwide MS registry in Argentina and…”
Get full text
Journal Article -
13
Assessing attacks and treatment response rates among adult patients with NMOSD and MOGAD: Data from a nationwide registry in Argentina
Published in Multiple sclerosis journal - experimental, translational and clinical (01-07-2021)“…We aimed to examine treatment interventions implemented in patients experiencing neuromyelitis optica spectrum disorders (NMOSD) attacks (frequency, types, and…”
Get full text
Journal Article -
14
Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry
Published in Multiple sclerosis journal - experimental, translational and clinical (01-10-2023)“…We aimed to evaluate mortality and causes of death among Argentinean neuromyelitis optica spectrum disorder (NMOSD) patients and identify predictors of death…”
Get full text
Journal Article -
15
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry
Published in Journal of the neurological sciences (15-06-2024)“…Knowledge of the safety and efficacy of disease-modifying therapies (DMTs) in older patients with Multiple Sclerosis (pwMS) is limited due to their exclusion…”
Get full text
Journal Article -
16
COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America: COVID-19 in MS and NMOSD patients in LATAM
Published in Multiple sclerosis and related disorders (01-06-2021)“…There is no data regarding COVID-19 in Multiple Sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) patients in Latin America. The objective of…”
Get full text
Journal Article -
17
Aggressive multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM
Published in Journal of clinical neuroscience (01-07-2021)“…•We describe and compare baseline characteristics in AMS and non-AMS in Argentina.•2158 patients with MS were included: 74 AMS and 2084 non-AMS.•The prevalence…”
Get full text
Journal Article -
18
What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM)
Published in Multiple sclerosis and related disorders (01-04-2021)“…•RelevarEM is the first nationwide MS and NMOSD registry in Argentina•Patients with phenotype of suspected NMOSD were evaluated•165 patients (79 AQP4-ab…”
Get full text
Journal Article -
19
COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America
Published in Multiple sclerosis and related disorders (01-06-2021)“…•RELACOEM is the first study conducted in LATAM evaluating risk of COVID-19 in patients with MS and NMOSD•We found an increased proportion of hospitalizations…”
Get full text
Journal Article -
20
Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM)
Published in Neurological sciences (01-06-2020)“…The objective of this study was to describe and compare the baseline epidemiological data of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder…”
Get full text
Journal Article